FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2210792013> ?p ?o ?g. }

• W2210792013 endingPage "248" @default.
• W2210792013 startingPage "242" @default.
• W2210792013 abstract "We assessed in this study the anti-asthmatic effects of ONO-6950, a novel cysteinyl leukotriene 1 (CysLT1) and 2 (CysLT2) receptors dual antagonist, in normal and S-hexyl glutathione (S-hexyl GSH)-treated guinea pigs, and compared these effects to those of montelukast, a CysLT1 selective receptor antagonist. Treatment with S-hexyl GSH reduced animals LTC4 metabolism, allowing practical evaluation of CysLT2 receptor-mediated airway response. ONO-6950 antagonized intracellular calcium signaling via human and guinea pig CysLT1 and CysLT2 receptors with IC50 values of 1.7 and 25 nM, respectively (human receptors) and 6.3 and 8.2 nM, respectively (guinea pig receptors). In normal guinea pigs, both ONO-6950 (1 or 0.3 mg/kg, p.o.) and the CysLT1 receptor antagonist montelukast (0.3 or 0.1 mg/kg, p.o.) fully attenuated CysLT1-mediated bronchoconstriction and airway vascular hyperpermeability induced by LTD4. On the other hand, in S-hexyl GSH-treated guinea pigs ONO-6950 at 3 mg/kg, p.o. or more almost completely inhibited bronchoconstriction and airway vascular hyperpermeability elicited by LTC4, while montelukast showed only partial or negligible inhibition of these airway responses. In ovalbumin sensitized guinea pigs, treatment with S-hexyl GSH on top of pyrilamine and indomethacin rendered antigen-induced bronchoconstriction sensitive to both CysLT1 and CysLT2 receptor antagonists. ONO-6950 strongly inhibited this asthmatic response to the level attained by combination therapy with montelukast and BayCysLT2RA, a selective CysLT2 receptor antagonist. These results clearly demonstrate that ONO-6950 is an orally active dual CysLT1/LT2 receptor antagonist that may provide a novel therapeutic option for patients with asthma." @default.
• W2210792013 created "2016-06-24" @default.
• W2210792013 creator A5003917963 @default.
• W2210792013 creator A5008706707 @default.
• W2210792013 creator A5010890436 @default.
• W2210792013 creator A5019427418 @default.
• W2210792013 creator A5021159504 @default.
• W2210792013 creator A5029806533 @default.
• W2210792013 creator A5030986205 @default.
• W2210792013 creator A5032740103 @default.
• W2210792013 creator A5037175573 @default.
• W2210792013 creator A5039891070 @default.
• W2210792013 creator A5048937040 @default.
• W2210792013 creator A5050328189 @default.
• W2210792013 creator A5052744115 @default.
• W2210792013 creator A5055593891 @default.
• W2210792013 date "2015-10-01" @default.
• W2210792013 modified "2023-10-05" @default.
• W2210792013 title "Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma" @default.
• W2210792013 cites W1488405627 @default.
• W2210792013 cites W1521691742 @default.
• W2210792013 cites W1926255205 @default.
• W2210792013 cites W1956709930 @default.
• W2210792013 cites W1966866092 @default.
• W2210792013 cites W1972104683 @default.
• W2210792013 cites W1980993116 @default.
• W2210792013 cites W1992226612 @default.
• W2210792013 cites W2004351423 @default.
• W2210792013 cites W2006214341 @default.
• W2210792013 cites W2009640513 @default.
• W2210792013 cites W2026086105 @default.
• W2210792013 cites W2031563193 @default.
• W2210792013 cites W2037544021 @default.
• W2210792013 cites W2051656004 @default.
• W2210792013 cites W2092001407 @default.
• W2210792013 cites W2096789558 @default.
• W2210792013 cites W2116594128 @default.
• W2210792013 cites W2126572754 @default.
• W2210792013 cites W2141905229 @default.
• W2210792013 cites W2144567143 @default.
• W2210792013 cites W2146319740 @default.
• W2210792013 cites W2172149963 @default.
• W2210792013 cites W2626246102 @default.
• W2210792013 doi "https://doi.org/10.1016/j.ejphar.2015.08.041" @default.
• W2210792013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26318198" @default.
• W2210792013 hasPublicationYear "2015" @default.
• W2210792013 type Work @default.
• W2210792013 sameAs 2210792013 @default.
• W2210792013 citedByCount "11" @default.
• W2210792013 countsByYear W22107920132016 @default.
• W2210792013 countsByYear W22107920132017 @default.
• W2210792013 countsByYear W22107920132018 @default.
• W2210792013 countsByYear W22107920132019 @default.
• W2210792013 countsByYear W22107920132020 @default.
• W2210792013 countsByYear W22107920132022 @default.
• W2210792013 crossrefType "journal-article" @default.
• W2210792013 hasAuthorship W2210792013A5003917963 @default.
• W2210792013 hasAuthorship W2210792013A5008706707 @default.
• W2210792013 hasAuthorship W2210792013A5010890436 @default.
• W2210792013 hasAuthorship W2210792013A5019427418 @default.
• W2210792013 hasAuthorship W2210792013A5021159504 @default.
• W2210792013 hasAuthorship W2210792013A5029806533 @default.
• W2210792013 hasAuthorship W2210792013A5030986205 @default.
• W2210792013 hasAuthorship W2210792013A5032740103 @default.
• W2210792013 hasAuthorship W2210792013A5037175573 @default.
• W2210792013 hasAuthorship W2210792013A5039891070 @default.
• W2210792013 hasAuthorship W2210792013A5048937040 @default.
• W2210792013 hasAuthorship W2210792013A5050328189 @default.
• W2210792013 hasAuthorship W2210792013A5052744115 @default.
• W2210792013 hasAuthorship W2210792013A5055593891 @default.
• W2210792013 hasConcept C126322002 @default.
• W2210792013 hasConcept C147483822 @default.
• W2210792013 hasConcept C170493617 @default.
• W2210792013 hasConcept C185592680 @default.
• W2210792013 hasConcept C203014093 @default.
• W2210792013 hasConcept C2776042228 @default.
• W2210792013 hasConcept C2776322731 @default.
• W2210792013 hasConcept C2776452501 @default.
• W2210792013 hasConcept C2776885963 @default.
• W2210792013 hasConcept C2776946954 @default.
• W2210792013 hasConcept C2777242621 @default.
• W2210792013 hasConcept C2778122271 @default.
• W2210792013 hasConcept C2778815084 @default.
• W2210792013 hasConcept C2779543280 @default.
• W2210792013 hasConcept C2780769369 @default.
• W2210792013 hasConcept C71924100 @default.
• W2210792013 hasConcept C98274493 @default.
• W2210792013 hasConceptScore W2210792013C126322002 @default.
• W2210792013 hasConceptScore W2210792013C147483822 @default.
• W2210792013 hasConceptScore W2210792013C170493617 @default.
• W2210792013 hasConceptScore W2210792013C185592680 @default.
• W2210792013 hasConceptScore W2210792013C203014093 @default.
• W2210792013 hasConceptScore W2210792013C2776042228 @default.
• W2210792013 hasConceptScore W2210792013C2776322731 @default.
• W2210792013 hasConceptScore W2210792013C2776452501 @default.
• W2210792013 hasConceptScore W2210792013C2776885963 @default.
• W2210792013 hasConceptScore W2210792013C2776946954 @default.
• W2210792013 hasConceptScore W2210792013C2777242621 @default.

• next